Public Employees Retirement System of Ohio bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 93,601 shares of the medical research company's stock, valued at approximately $12,433,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after purchasing an additional 24,687 shares in the last quarter. Bank of Nova Scotia acquired a new stake in shares of Agilent Technologies in the 2nd quarter valued at about $58,539,000. Dudley & Shanley Inc. boosted its position in shares of Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company's stock valued at $9,232,000 after purchasing an additional 14,300 shares during the period. BIP Wealth LLC purchased a new position in Agilent Technologies during the 2nd quarter worth approximately $834,000. Finally, Crossmark Global Holdings Inc. increased its position in Agilent Technologies by 39.6% during the fourth quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company's stock worth $4,615,000 after buying an additional 9,615 shares during the period.
Key Headlines Impacting Agilent Technologies
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
- Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
- Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.
Analyst Ratings Changes
A number of equities research analysts have weighed in on A shares. Robert W. Baird boosted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research note on Tuesday, May 26th. JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies from $180.00 to $190.00 and gave the company an "overweight" rating in a research note on Thursday. Morgan Stanley upped their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an "overweight" rating in a report on Wednesday, August 12th. TD Cowen increased their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock a "buy" rating in a research note on Thursday. Finally, Bank of America raised their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock a "buy" rating in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $170.33.
Check Out Our Latest Research Report on Agilent Technologies
Agilent Technologies Stock Performance
NYSE:A opened at $154.47 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a market cap of $43.63 billion, a price-to-earnings ratio of 30.41, a price-to-earnings-growth ratio of 2.34 and a beta of 1.25. The firm's fifty day moving average price is $140.30 and its 200 day moving average price is $127.04. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts' consensus estimates of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the firm earned $1.37 EPS. Agilent Technologies's quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 6.2 EPS for the current year.
About Agilent Technologies
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
